The burgeoning field of obesity management has witnessed remarkable advancements with the emergence of dual GLP-3 receptor agonists, notably Retatrutide and Trizepatide. These innovative therapies represent a https://kiarancox242446.tusblogos.com/39174653/glp-3-receptor-agonists-retatrutide-trizepatide